Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 07:50 am Sale |
2020-12-31 | 13G | BIOSPECIFICS TECHNOLOGIES CORP BSTC |
RICE HALL JAMES & ASSOCIATES LLC | 0 0.000% |
-369,146 (Position Closed) |
Filing History |
| 2021-02-10 4:04 pm Sale |
2020-12-31 | 13G | BIOSPECIFICS TECHNOLOGIES CORP BSTC |
Renaissance Technologies LLC | 0 0.000% |
-576,247 (Position Closed) |
Filing History |
| 2020-12-03 8:26 pm Sale |
2020-12-02 | 13D | BIOSPECIFICS TECHNOLOGIES CORP BSTC |
Endo International plc ENDP |
100 100.000% |
-934,973 (-99.99%) |
Filing History |
| 2020-12-02 09:32 am Sale |
2006-08-10 | 13D | BIOSPECIFICS TECHNOLOGIES CORP BSTC |
Wegman Toby | 0 0.000% |
-1,002,235 (Position Closed) |
Filing History |
| 2020-10-29 6:27 pm Purchase |
2006-08-10 | 13D | BIOSPECIFICS TECHNOLOGIES CORP BSTC |
Wegman Toby | 1,002,235 13.700% |
1,002,235 (New Position) |
Filing History |
| 2020-10-29 5:24 pm Purchase |
2020-10-19 | 13D | BIOSPECIFICS TECHNOLOGIES CORP BSTC |
Endo International plc ENDP |
935,073 12.700% |
935,073 (New Position) |
Filing History |